Muscle Dysmorphia and Anabolic‑Androgenic Steroids Use: A Systematic Review

• Autor(a) principal: Correia, Susana Amaral
• Data de Publicação: 2020
• Outros Autores: Coentre, Ricardo
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: https://doi.org/10.51338/rppsm.2020.v6.i1.97
• topic: Anabolic Agents; Body Dysmorphic Disorder; Body Image; Testosterone Congeners; Anabolizantes; Congéneres da Testosterona; Imagem Corporal; Perturbação Dismórfica Corporal

Introduction: Muscular dysmorphia (DM) is a subtype of body dysmorphic disorder, which occurs in individuals who, despite having a muscularly developed physique, consider themselves thin and weak. Currently, it is assumed that the use of androgen‑anabolic steroids (AAS) may be a perpetuating factor in this disorder, but also that DM may predispose to the use of AAS, drugs frequently used for their effects on body composition, namely the increase in muscle mass body composition, but with vast side effects. This systematic review aimed to explore the current evidence about the association between DM and the use of AAS. Methods: Systematic review of recent literature, including articles published between June 2009 and January 2019. Results: Twelve articles were included, with the majority of studies establishing an association between these two variables, the results oscillating between the absence of statistically significant differences and a strong association, the latter being the most frequently found. Conclusion: The existing evidence of the association between DM and the use of AAS is still not very consistent, which may be due to the heterogeneity of the tools used to compare the same variables. Thus, it is important to establish an optimal model for collecting more sensitive information, and to establish better validated DM assessment scales, so that data collection and analysis can be as accurate as possible.